Intended for healthcare professionals

  1. Research
  2. Collaborative meta...
  3. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
Papers

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

BMJ 2002; 324 doi: https://doi.org/10.1136/bmj.324.7329.71 (Published 12 January 2002) Cite this as: BMJ 2002;324:71

Data supplement

  • BMJ 2002; 324:71 (12 Jan)

    CORRECTION (10 Jan 2002)

    The last sentence of this article has been corrected on the website to read: "For most healthy individuals, however, for whom the risk of a vascular event is likely to be substantially less than 1% a year, daily aspirin may well be inappropriate."

    The online text therefore differs from the text that appears in the paper journal [which incorrectly ended "...may well be appropriate."]

    A corrected pdf is available here

Related articles

See more

Cited by...

  • Quality of care for secondary cardiovascular disease prevention in 2009-2017: population-wide cohort study of antiplatelet therapy use in Scotland
  • Aspirin: latest evidence and developments
  • Percutaneous coronary intervention plus medical therapy versus medical therapy alone in chronic coronary syndrome: a propensity score-matched analysis from the Swedish Coronary Angiography and Angioplasty Registry
  • Development and validation of a tool to stratify the treatment effect of low-dose aspirin in patients with cardiovascular disease: VISTA (Vascular Intervention Stratification Tool for Aspirin)
  • Efficacy and safety of dual antiplatelet therapy in the elderly for stroke prevention: a subgroup analysis of the CHANCE-2 trial
  • Outcomes of Antiplatelet Therapy Continuation in Older Hypertensive Adults With Peptic Ulcer Disease
  • Addition of aspirin to venous thromboembolism chemoprophylaxis safely decreases venous thromboembolism rates in trauma patients
  • Antiplatelet therapy and long-term mortality in patients with myocardial injury after non-cardiac surgery
  • Discharge prescription patterns for antiplatelet and statin therapy following carotid endarterectomy: an analysis of the vascular quality initiative
  • Estimating the Cardiovascular Disease Risk Reduction of a Quality Improvement Initiative in Primary Care: Findings from EvidenceNOW
  • Estimating the Cardiovascular Disease Risk Reduction of a Quality Improvement Initiative in Primary Care: Findings from EvidenceNOW
  • Aspirin in primary prevention of cardiovascular events: Key questions remain
  • Heartwatch: an Irish cardiovascular secondary prevention programme in primary care, a secondary analysis of patient outcomes
  • Long-term Risk of Bleeding and Ischemic Events After Ischemic Stroke or Transient Ischemic Attack in Young Adults
  • Analysis of the relationship between sex and prescriptions for guideline-recommended therapy in peripheral arterial disease, in relation to 1-year all-cause mortality: a primary care cohort study
  • Platelet Abnormalities in CKD and Their Implications for Antiplatelet Therapy
  • Cardiovascular prevention trials: cross-examining colchicine
  • Primary care providers should prescribe aspirin to prevent cardiovascular disease based on benefit-risk ratio, not age
  • Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
  • Antithrombotic therapy for patients with chronic coronary syndromes
  • Antithrombotic regimens in females with symptomatic lower extremity peripheral arterial disease: protocol for a systematic review and meta-analysis
  • Selecting an Optimal Antiplatelet Agent for Secondary Stroke Prevention
  • Remote platelet function testing using P-selectin expression in patients with recent cerebral ischaemia on clopidogrel
  • The management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: key points from the ESC 2020 Clinical Practice Guidelines for the general and emergency physician
  • P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trials
  • Rare pulmonary embolism caused by the combination of bilateral popliteal venous aneurysms and antiphospholipid syndrome
  • CYP2C19*2, CYP2C19*17 and ITGB3 (PlA1/A2) polymorphisms and resulting therapeutic alterations of clopidogrel and aspirin: A clinical screening among CVD patients who undergone PCI
  • Recommandations canadiennes pour les pratiques optimales de soins de lAVC, septieme edition : lacide acetylsalicylique pour la prevention devenements vasculaires
  • Aspirin in Primary Prevention of Cardiovascular Events
  • Evaluating the effectiveness of a support programme for people with type 2 diabetes mellitus in primary care: an observational prospective study in Ecuador
  • Canadian Stroke Best Practice Recommendations, seventh edition: acetylsalicylic acid for prevention of vascular events
  • Angiopathy with impaired glucose logistics observed in schizophrenia-like model mice
  • Preventive Management of Nonobstructive CAD After Coronary CT Angiography in the Emergency Department
  • Impact of updated recommendations on acetylsalicylic acid use for primary prevention of cardiovascular disease in Canada: a population-based survey
  • Aspirin for primary prevention of CVD in CKD: where do we stand?
  • Temporal variation in the diagnosis of resolved atrial fibrillation and the influence of performance targets on clinical coding: cohort study
  • Ticagrelor Alone Versus Dual Antiplatelet Therapy From 1 Month After Drug-Eluting Coronary Stenting
  • Optimising fitness for major vascular surgery
  • Degree of serotonin reuptake inhibition of antidepressants and ischemic risk: A cohort study
  • Antithrombotics: From Aspirin to DOACs in Coronary Artery Disease and Atrial Fibrillation (Part 3/5)
  • Low Level LASER Therapy Induces Therapeutic Angiogenesis in Diabetic Mice with Hindlimb Ischemia
  • Secondary prevention therapies in acute coronary syndrome and relation to outcomes: observational study
  • Clopidogrel plus aspirin versus aspirin alone for acute minor ischaemic stroke or high risk transient ischaemic attack: systematic review and meta-analysis
  • Medical Therapy for Long-Term Prevention of Atherothrombosis Following an Acute Coronary Syndrome: JACC State-of-the-Art Review
  • ACC/AHA Versus ESC Guidelines for Diagnosis and Management of Peripheral Artery Disease: JACC Guideline Comparison
  • Humanized GPIb{alpha}-von Willebrand factor interaction in the mouse
  • Antiplatelet Treatment After Transient Ischemic Attack and Ischemic Stroke in Patients With Cerebral Microbleeds in 2 Large Cohorts and an Updated Systematic Review
  • Antithrombotic Therapy for Peripheral Artery Disease: Recent Advances
  • Risk of stroke and transient ischaemic attack in patients with a diagnosis of resolved atrial fibrillation: retrospective cohort studies
  • In-Hospital Outcomes of Dual Loading Antiplatelet Therapy in Patients 75 Years and Older With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Findings From the CCC-ACS (Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome) Project
  • A protocol for an economic evaluation of a polypill in patients with established or at high risk of cardiovascular disease in a UK NHS setting: RUPEE (NHS) study
  • Anti-inflammatory approaches to ischaemic stroke prevention
  • TEXT messages to improve MEDication adherence and Secondary prevention (TEXTMEDS) after acute coronary syndrome: a randomised clinical trial protocol
  • Impact of hepatitis C virus infection on long-term mortality after acute myocardial infarction: a nationwide population-based, propensity-matched cohort study in Taiwan
  • Reduced Long-Term Risk of Aortic Aneurysm and Aortic Dissection Among Individuals With Type 2 Diabetes Mellitus: A Nationwide Observational Study
  • Antithrombotic Therapy in Peripheral Artery Disease: Generating and Translating Evidence Into Practice
  • Preventing cardiovascular disease in older adults: One size does not fit all
  • When has service provision for transient ischaemic attack improved enough? A discrete event simulation economic modelling study
  • Procoagulant platelets: generation, function, and therapeutic targeting in thrombosis
  • Aspirin and the prevention of venous thromboembolism following total joint arthroplasty: commonly asked questions
  • 2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures
  • Smoking cessation and outcome after ischemic stroke or TIA
  • Antiplatelet Agents for the Treatment and Prevention of Coronary Atherothrombosis
  • Acute monocular vision loss: Dont lose sight of the differential
  • Contribution of whole platelet aggregometry to the endovascular management of unruptured aneurysms: an institutional experience
  • Management of acute coronary syndromes: special considerations in women
  • Low-Dose Aspirin Discontinuation and Risk of Cardiovascular Events: A Swedish Nationwide, Population-Based Cohort Study
  • 2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures
  • Efficacy and Safety of Ticagrelor Over Time in Patients With Prior MI in PEGASUS-TIMI 54
  • The role of contraindications in prescribing anticoagulants to patients with atrial fibrillation: a cross-sectional analysis of primary care data in the UK
  • Aspirin Monotherapy Should Not Be Recommended for Cardioprotection in Patients With Symptomatic Peripheral Artery Disease
  • Predicting major bleeding in patients with noncardioembolic stroke on antiplatelets: S2TOP-BLEED
  • What Do Cardiology and Homeopathy Have in Common?: A Belief in Aspirin?
  • One-Year Incidence, Time Trends, and Predictors of Recurrent Ischemic Stroke in Sweden From 1998 to 2010: An Observational Study
  • A Structured Review of Antithrombotic Therapy in Peripheral Artery Disease With a Focus on Revascularization: A TASC (InterSociety Consensus for the Management of Peripheral Artery Disease) Initiative
  • Thrombosis in diabetes: a shear flow effect?
  • Newly Formed Reticulated Platelets Undermine Pharmacokinetically Short-Lived Antiplatelet Therapies
  • Primary Prevention of Myocardial Infarction in Rheumatoid Arthritis Using Aspirin: A Case-crossover Study and a Propensity Score-matched Cohort Study
  • Potent P2Y12 Inhibitors in Men Versus Women: A Collaborative Meta-Analysis of Randomized Trials
  • 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
  • 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
  • 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
  • 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
  • Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: 10-Year Follow-Up of a Randomized Controlled Trial
  • Prevention of Stroke in Patients With Silent Cerebrovascular Disease: A Scientific Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
  • Aspirin Desensitization in Patients With Coronary Artery Disease: Results of the Multicenter ADAPTED Registry (Aspirin Desensitization in Patients With Coronary Artery Disease)
  • Low-Dose Aspirin Is Effective Chemoprophylaxis Against Clinically Important Venous Thromboembolism Following Total Joint Arthroplasty: A Preliminary Analysis
  • A Critical Appraisal of Aspirin in Secondary Prevention: Is Less More?
  • Using Large-Scale Linkage Data to Evaluate the Effectiveness of a National Educational Program on Antithrombotic Prescribing and Associated Stroke Prevention in Primary Care
Back to top